Cargando…

PB1744: THE RATIO OF ABSOLUTE LYMPHOCYTE COUNT AT INTERIM OF THERAPY TO ABSOLUTE LYMPHOCYTE COUNT AT DIAGNOSIS PREDICTS SURVIVAL IN ACUTE LYMPHOBLASTIC LEUKEMIA

Detalles Bibliográficos
Autores principales: Faiza, Talbi, Rafik, Abbadi, Hakim, Otsmane, Leila, Sahraoui, Aissa, Bachiri, Salah, Belakehal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429807/
http://dx.doi.org/10.1097/01.HS9.0000973836.28150.78
_version_ 1785090804159610880
author Faiza, Talbi
Rafik, Abbadi
Hakim, Otsmane
Leila, Sahraoui
Aissa, Bachiri
Salah, Belakehal
author_facet Faiza, Talbi
Rafik, Abbadi
Hakim, Otsmane
Leila, Sahraoui
Aissa, Bachiri
Salah, Belakehal
author_sort Faiza, Talbi
collection PubMed
description
format Online
Article
Text
id pubmed-10429807
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104298072023-08-17 PB1744: THE RATIO OF ABSOLUTE LYMPHOCYTE COUNT AT INTERIM OF THERAPY TO ABSOLUTE LYMPHOCYTE COUNT AT DIAGNOSIS PREDICTS SURVIVAL IN ACUTE LYMPHOBLASTIC LEUKEMIA Faiza, Talbi Rafik, Abbadi Hakim, Otsmane Leila, Sahraoui Aissa, Bachiri Salah, Belakehal Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429807/ http://dx.doi.org/10.1097/01.HS9.0000973836.28150.78 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Faiza, Talbi
Rafik, Abbadi
Hakim, Otsmane
Leila, Sahraoui
Aissa, Bachiri
Salah, Belakehal
PB1744: THE RATIO OF ABSOLUTE LYMPHOCYTE COUNT AT INTERIM OF THERAPY TO ABSOLUTE LYMPHOCYTE COUNT AT DIAGNOSIS PREDICTS SURVIVAL IN ACUTE LYMPHOBLASTIC LEUKEMIA
title PB1744: THE RATIO OF ABSOLUTE LYMPHOCYTE COUNT AT INTERIM OF THERAPY TO ABSOLUTE LYMPHOCYTE COUNT AT DIAGNOSIS PREDICTS SURVIVAL IN ACUTE LYMPHOBLASTIC LEUKEMIA
title_full PB1744: THE RATIO OF ABSOLUTE LYMPHOCYTE COUNT AT INTERIM OF THERAPY TO ABSOLUTE LYMPHOCYTE COUNT AT DIAGNOSIS PREDICTS SURVIVAL IN ACUTE LYMPHOBLASTIC LEUKEMIA
title_fullStr PB1744: THE RATIO OF ABSOLUTE LYMPHOCYTE COUNT AT INTERIM OF THERAPY TO ABSOLUTE LYMPHOCYTE COUNT AT DIAGNOSIS PREDICTS SURVIVAL IN ACUTE LYMPHOBLASTIC LEUKEMIA
title_full_unstemmed PB1744: THE RATIO OF ABSOLUTE LYMPHOCYTE COUNT AT INTERIM OF THERAPY TO ABSOLUTE LYMPHOCYTE COUNT AT DIAGNOSIS PREDICTS SURVIVAL IN ACUTE LYMPHOBLASTIC LEUKEMIA
title_short PB1744: THE RATIO OF ABSOLUTE LYMPHOCYTE COUNT AT INTERIM OF THERAPY TO ABSOLUTE LYMPHOCYTE COUNT AT DIAGNOSIS PREDICTS SURVIVAL IN ACUTE LYMPHOBLASTIC LEUKEMIA
title_sort pb1744: the ratio of absolute lymphocyte count at interim of therapy to absolute lymphocyte count at diagnosis predicts survival in acute lymphoblastic leukemia
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429807/
http://dx.doi.org/10.1097/01.HS9.0000973836.28150.78
work_keys_str_mv AT faizatalbi pb1744theratioofabsolutelymphocytecountatinterimoftherapytoabsolutelymphocytecountatdiagnosispredictssurvivalinacutelymphoblasticleukemia
AT rafikabbadi pb1744theratioofabsolutelymphocytecountatinterimoftherapytoabsolutelymphocytecountatdiagnosispredictssurvivalinacutelymphoblasticleukemia
AT hakimotsmane pb1744theratioofabsolutelymphocytecountatinterimoftherapytoabsolutelymphocytecountatdiagnosispredictssurvivalinacutelymphoblasticleukemia
AT leilasahraoui pb1744theratioofabsolutelymphocytecountatinterimoftherapytoabsolutelymphocytecountatdiagnosispredictssurvivalinacutelymphoblasticleukemia
AT aissabachiri pb1744theratioofabsolutelymphocytecountatinterimoftherapytoabsolutelymphocytecountatdiagnosispredictssurvivalinacutelymphoblasticleukemia
AT salahbelakehal pb1744theratioofabsolutelymphocytecountatinterimoftherapytoabsolutelymphocytecountatdiagnosispredictssurvivalinacutelymphoblasticleukemia